ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for June 2018

Motivated, Engaged, and Organized: The New Molecular Cohorts of Lung Cancer

on: June 04, 2018In: Patient Advocacy & Survivorship
Motivated, Engaged, and Organized: The New Molecular Cohorts of Lung Cancer

By D.R. Camidge Posted: June 2018 Just as physicians and scientists no longer treat lung cancer as a single disease because of molecular distinctions, patient advocacy groups also are becoming […] Read more


HLA LOH As an Immune Evasive Mechanism in TRACERx NSCLC

on: June 04, 2018In: Evolving Standards of Care
HLA LOH As an Immune Evasive Mechanism in TRACERx NSCLC

By Rachel Rosenthal, PhD, MSc, andCharles Swanton, FRCP, BSc, PhD Posted: June 2018 An evolving tumor and the immune system continuously adapt to each other. As a tumor develops increasing […] Read more

Israel's Parliament Hosts IASLC CEO Dr. Fred R. Hirsch

on: June 04, 2018In: Global Initiatives
Israel's Parliament Hosts IASLC CEO Dr. Fred R. Hirsch

By Shani Shilo, DMD, PhD, andNir Peled, MD, PhD, FCCP Posted: June 2018 On March 6, 2018, the Israeli parliament, the Knesset, held a Science and Technology Committee meeting devoted […] Read more

NCCN Guidelines Updated for 2018: Keeping Pace with Data

on: June 04, 2018In: Evolving Standards of Care
NCCN Guidelines Updated for 2018: Keeping Pace with Data

By Gregory J. Riely, MD Posted: June 2018 The changes seen in the 2018 update of the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for […] Read more

Fabrice Barlesi, MD

on: June 01, 2018In: Names & News
Fabrice Barlesi, MD

Posted: June 2018 The 2018 Heine H. Hansen Award recipient was IASLC Lung Cancer News Associate Editor Fabrice Barlesi, MD. The award was presented at the 2018 European Lung Cancer […] Read more

Frances Shepherd, MD

on: June 01, 2018In: Names & News
Frances Shepherd, MD

Posted: June 2018 IASLC past-president Frances Shepherd, MD, has been awarded the 2018 Canada Gairdner Wightman Award for outstanding career leadership in medicine and medical science. Dr. Shepherd is a […] Read more

Pasi A. Janne, MD, PhD

on: June 01, 2018In: Names & News
Pasi A. Janne, MD, PhD

Posted: June 2018 Pasi A. Janne, MD, PhD, was awarded the Second AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. The award is given to […] Read more

Primo N. Lara, Jr., MD

on: June 01, 2018In: Names & News
Primo N. Lara, Jr., MD

Posted: June 2018 Primo N. Lara, Jr., MD, has been named director of the National Cancer Institute–designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists […] Read more

The Long Road Home

on: June 01, 2018In: Meeting News
The Long Road Home

Figure. Prevalance of Water Pipe Usage Is Virtually at Epidemic Proportion in Parts of the Middle East Sources: Vardavas C, Filippidis F, Agaku I. http://tobaccocontrol.bmj.com. Accessed April 11, 2018. McKelvey […] Read more

EGFR-Targeted Therapy: A New Beginning

on: June 01, 2018In: Meeting News
EGFR-Targeted Therapy: A New Beginning

Highlights from the IASLC 18th Lung Cancer Targeted Therapies Meeting keynote address. By Suresh S. Ramalingam, MD Posted: June 2018 EGFR-targeted therapy has entered a new phase as the result […] Read more

12

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy